These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1778298)

  • 1. The role of ligand in estrogen receptor regulation of gene expression.
    Murdoch FE; Gorski J
    Mol Cell Endocrinol; 1991 Jul; 78(3):C103-8. PubMed ID: 1778298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes.
    Curtis SW; Korach KS
    Mol Endocrinol; 1990 Feb; 4(2):276-86. PubMed ID: 2330006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine estrogen receptor-DNA complexes: effects of different ERE sequences, ligands, and receptor forms.
    Curtis SW; Korach KS
    Mol Endocrinol; 1991 Jul; 5(7):959-66. PubMed ID: 1944301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
    Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
    Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain.
    Fritsch M; Leary CM; Furlow JD; Ahrens H; Schuh TJ; Mueller GC; Gorski J
    Biochemistry; 1992 Jun; 31(23):5303-11. PubMed ID: 1606154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between a half-site and an imperfect estrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene.
    Petit FG; Métivier R; Valotaire Y; Pakdel F
    Eur J Biochem; 1999 Jan; 259(1-2):385-95. PubMed ID: 9914518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 90 kDa heat-shock protein (hsp90) modulates the binding of the oestrogen receptor to its cognate DNA.
    Sabbah M; Radanyi C; Redeuilh G; Baulieu EE
    Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):205-13. PubMed ID: 8660284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F; Reese JC; Katzenellenbogen BS
    Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of estrogen receptor conformation by different estrogen response elements.
    Wood JR; Likhite VS; Loven MA; Nardulli AM
    Mol Endocrinol; 2001 Jul; 15(7):1114-26. PubMed ID: 11435612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.
    Beekman JM; Allan GF; Tsai SY; Tsai MJ; O'Malley BW
    Mol Endocrinol; 1993 Oct; 7(10):1266-74. PubMed ID: 8264659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
    Schaufele F
    Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ligand and DNA binding on the interaction between human transcription intermediary factor 1alpha and estrogen receptors.
    Thénot S; Bonnet S; Boulahtouf A; Margeat E; Royer CA; Borgna JL; Cavaillès V
    Mol Endocrinol; 1999 Dec; 13(12):2137-50. PubMed ID: 10598587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
    Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
    Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA bending by nuclear receptors.
    Nardulli AM; Shapiro DJ
    Receptor; 1993; 3(4):247-55. PubMed ID: 8142903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain.
    Adler S; Waterman ML; He X; Rosenfeld MG
    Cell; 1988 Mar; 52(5):685-95. PubMed ID: 3345568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.